Skip to main content


Fig. 5 | Cardiovascular Diabetology

Fig. 5

From: Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet/streptozotocin-induced diabetic rats

Fig. 5

Effects of EMPA on mitochondrial state 3 respiration (a), state 4 respiration (b), respiratory control ratio (RCR) (c), and mitochondrial membrane potential (d). *Compared with the control group, p < 0.05; **compared with the diabetes mellitus (DM) group, p < 0.05. Each group included 5 rats

Back to article page